DexCom
DXCM
79.32
-0.87
-1.08%
DexCom
US · DXCM
#635 by market cap
Listed 2005
79.32
-0.87
-1.08%
Periodic snapshot; not a real-time feed.
· 2026-11-20 20:02
Recent news
-
Company notice
DexCom | 4: Statement of changes in beneficial ownership of securities-Director Ashley Euan A.SEC · 2025/10/29
-
Rating change
Wells Fargo Maintains DexCom(DXCM.US) With Buy Rating, Maintains Target Price $90Market Newswire · 2026/10/15
-
Rating change
Truist Financial Maintains DexCom(DXCM.US) With Buy Rating, Maintains Target Price $102Market Newswire · 2026/9/24
-
Company notice
DexCom | 4: Statement of changes in beneficial ownership of securities-Director Ashley Euan A.SEC · 2026/6/2
-
Rating change
Citi Maintains DexCom(DXCM.US) With Buy Rating, Raises Target Price to $105Market Newswire · 2026/8/14
-
Rating change
Truist Financial Maintains DexCom(DXCM.US) With Buy Rating, Raises Target Price to $102Market Newswire · 2026/9/18
-
Rating change
Barclays Initiates DexCom(DXCM.US) With Buy Rating, Announces Target Price $115Market Newswire · 2026/10/8
-
Rating change
BTIG Maintains DexCom(DXCM.US) With Buy Rating, Raises Target Price to $96Market Newswire · 2026/10/12
-
Company notice
DexCom | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-BlackRock, Inc.(10.4%)SEC · 2024/12/7
-
Rating change
TD Cowen Maintains DexCom(DXCM.US) With Buy Rating, Maintains Target Price $95Market Newswire · 2026/9/18
-
BofA Securities Maintains DexCom(DXCM.US) With Buy RatingMarket Newswire · 2026/11/19
-
Citi Maintains DexCom(DXCM.US) With Buy Rating, Maintains Target Price $105Market Newswire · 2026/10/21
-
A Quick Look at Today's Ratings for DexCom(DXCM.US), With a Forecast Between $85 to $120Market Newswire · 2026/10/31
-
Rating change
RBC Capital Maintains DexCom(DXCM.US) With Buy Rating, Raises Target Price to $105Market Newswire · 2026/10/1
-
Barclays Upgrades DexCom(DXCM.US) to Buy Rating, Raises Target Price to $115Market Newswire · 2026/10/7
-
Company notice
DexCom | 3: Initial statement of beneficial ownership of securities-Director Ashley Euan A.SEC · 2025/10/29
-
Rating change
RBC Capital Initiates DexCom(DXCM.US) With Buy Rating, Announces Target Price $105Market Newswire · 2026/10/3
-
Company notice
DexCom | 4: Statement of changes in beneficial ownership of securities-Director Ashley Euan A.SEC · 2026/11/4
-
A Quick Look at Today's Ratings for DexCom(DXCM.US), With a Forecast Between $95 to $120Market Newswire · 2026/10/30
-
Rating change
Mizuho Securities Maintains DexCom(DXCM.US) With Buy Rating, Raises Target Price to $100Market Newswire · 2026/10/13
-
BofA Securities Maintains DexCom(DXCM.US) With Buy RatingMarket Newswire · 2026/10/23
-
Rating change
Mizuho Securities Maintains DexCom(DXCM.US) With Buy Rating, Maintains Target Price $95Market Newswire · 2026/8/4
-
Company notice
DexCom | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-BlackRock, Inc.(8.5%)SEC · 2024/1/26
-
Rating change
Argus Research Maintains DexCom(DXCM.US) With Buy Rating, Raises Target Price to $96Market Newswire · 2026/8/4
-
Rating change
A Quick Look at Today's Ratings for DexCom(DXCM.US), With a Forecast Between $82 to $105Market Newswire · 2026/7/31
Headlines are aggregated automatically and are not independently verified or edited by our team.
Quote time 2026-11-20 20:02:21 · For reference only, not investment advice and not tailored to your situation.
DexCom discussion 0 comments